TrialBritish journal of haematology2019

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).

Cara A Rosenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.